Compositional analysis of dietary patterns.


Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 27 7 2018
medline: 3 11 2020
entrez: 27 7 2018
Statut: ppublish

Résumé

Instead of looking at individual nutrients or foods, dietary pattern analysis has emerged as a promising approach to examine the relationship between diet and health outcomes. Despite dietary patterns being compositional (i.e. usually a higher intake of some foods implies that less of other foods are being consumed), compositional data analysis has not yet been applied in this setting. We describe three compositional data analysis approaches (compositional principal component analysis, balances and principal balances) that enable the extraction of dietary patterns by using control subjects from the Spanish multicase-control (MCC-Spain) study. In particular, principal balances overcome the limitations of purely data-driven or investigator-driven methods and present dietary patterns as trade-offs between eating more of some foods and less of others.

Identifiants

pubmed: 30045678
doi: 10.1177/0962280218790110
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2834-2847

Auteurs

M Solans (M)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
2 Research Group on Statistics, Econometrics and Health (GRECS), Universitat de Girona, Girona, Spain.
3 Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain.

G Coenders (G)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
2 Research Group on Statistics, Econometrics and Health (GRECS), Universitat de Girona, Girona, Spain.

R Marcos-Gragera (R)

2 Research Group on Statistics, Econometrics and Health (GRECS), Universitat de Girona, Girona, Spain.
3 Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain.

A Castelló (A)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
4 Cancer Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
5 Faculty of Medicine, University of Alcalá, Alcalá de Henares, Madrid, Spain.

E Gràcia-Lavedan (E)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
6 ISGlobal, Barcelona, Spain.
7 ISGlobal, Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Y Benavente (Y)

8 Unit of molecular and genetic epidemiology in infections and cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.

V Moreno (V)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
9 Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO). Hospitalet de Llobregat, Barcelona, Spain.
10 Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL). Hospitalet de Llobregat, Barcelona, Spain.
11 Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.

B Pérez-Gómez (B)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
12 Cardiovascular and Metabolic Diseases Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

P Amiano (P)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
13 Public Health Division of Gipuzkoa, BioDonostia Research Institute, Health Department, Basque Country, San Sebastian, Spain.

T Fernández-Villa (T)

14 Instituto de Biomedicina, Universidad de León, León, Spain.

M Guevara (M)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
15 Instituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain.

I Gómez-Acebo (I)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
16 Universidad de Cantabria - IDIVAL, Santander, Spain.

G Fernández-Tardón (G)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
17 IUOPA, Universidad de Oviedo, Asturias, Spain.

M Vanaclocha-Espi (M)

18 Cancer and Public Health Area, FISABIO - Public Health, Valencia, Spain.

M D Chirlaque (MD)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
19 Department of Epidemiology, Regional Health Authority, IMIB-Arrixaca, Murcia University, Murcia, Spain.

R Capelo (R)

20 Centro de Investigación en Recursos Naturales, Salud y medio Ambiente (RENSMA), Universidad de Huelva, Huelva, Spain.

R Barrios (R)

21 Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Granada, Granada, Spain.

N Aragonés (N)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
22 Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.

A Molinuevo (A)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

F Vitelli-Storelli (F)

14 Instituto de Biomedicina, Universidad de León, León, Spain.

J Castilla (J)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
15 Instituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain.

T Dierssen-Sotos (T)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
16 Universidad de Cantabria - IDIVAL, Santander, Spain.

G Castaño-Vinyals (G)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
6 ISGlobal, Barcelona, Spain.
7 ISGlobal, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
23 IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

M Kogevinas (M)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
6 ISGlobal, Barcelona, Spain.
7 ISGlobal, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
23 IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

M Pollán (M)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
4 Cancer Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

M Saez (M)

1 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
2 Research Group on Statistics, Econometrics and Health (GRECS), Universitat de Girona, Girona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH